Updated Jul 16, 2026
Hamilton James C has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.12M.
James C. Hamilton is the Chief Medical Officer at Arrowhead Pharmaceuticals, Inc., a biotechnology company focused on developing treatments for genetic diseases. He has been involved in the company's operations as indicated by his role and SEC filings.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-24 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale | 10.0K | $75.00 | $750K |
| 2026-03-09 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 10.0K | $64.19 | $642K |
| 2025-10-01 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale | 20.0K | $35.00 | $700K |
| 2025-09-12 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale | 15.0K | $30.00 | $450K |
| 2025-09-02 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale | 15.0K | $25.00 | $375K |
| 2025-08-13 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale | 9.4K | $20.00 | $188K |
| 2025-08-13 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | S — Open-market sale | 611 | $20.00 | $12K |
James C. Hamilton is the Chief Medical Officer at Arrowhead Pharmaceuticals, Inc., a biotechnology company focused on developing treatments for genetic diseases. He has been involved in the company's operations as indicated by his role and SEC filings.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($3.12M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hamilton James C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.